General Cardiology Research


Investigator-Initiated Research

Michelle Albert, MD Adversity and Health: Mapping a Road to Advantaged Educational and Health Outcomes in Diverse Children and Their Caregivers - A Novel Collaboration between DiverseCity and the NURTURE Center, UCSF Cardiology Internal Funding
Michelle Albert, MD  ObeSity and Jobs in SoCioeconomically Disadvantaged CommUnities: A Randomized CLinical Precision Public HealTh Intervention American Heart Assn. (National Office)
Rima Arnaout, MD Querying Biobank Resources at UCSF Internal Funding
Gordon Fung, MD Cardiac Ischemia Detection by Quantitative Electrocardiographic Detector (QED) Dynacardia, Inc.
Gregory Marcus, MD Validation of Administrative Database Codes Internal Funding
Gregory Marcus, MD Eureka #003: N-of-1 Experiments to Answer Patient Generated Research Questions Patient-CenteredOutcomes Research Institute
Gregory Marcus, MD Population Exposures and Short-Term Cardiovascular Outcomes Internal Funding
Gregory Marcus, MD Predictors of sleep quality and duration in an ambulatory cohort Internal Funding
Gregory Marcus, MD  Machine Learning Prediction of Blood Alcohol Content: A Digital Signature of Behavior Internal Funding
Gregory Marcus, MD  Study to Assess the Agreement of Measures Derived from a Smart Home Sleep Monitoring System and Conventional Polysomnography Internal Funding
Gregory Marcus, MD  Alcohol Pilot Study Internal Funding
Jeffrey Olgin, MD / Greg Marcus, MD Health eHeart Study NIH/Division
Jeffrey Olgin, MD Health eHeart Study/Eureka mHealth Research Platform - Beta Test Internal Funding
Jeffrey Olgin, MD Health eHeart Study Patient-Centered Outcomes Research Inst, NIH Natl Heart, Lung & Blood Institute, UC Tobacco-Related Disease Research Pgm
Jeffrey Olgin, MD HeH Ancillary Study #002 - Health eHeart Methodology Validation Study Internal Funding
Jeffrey Olgin, MD Eureka: An Mobile Health (mHealth) Research Platform NIH Natl Inst of Biomed Imaging & Bioeng, Patient-Centered Outcomes Research Inst, St. Jude Children's Research Hospital, NIH Natl Cancer Institute, NIH Natl Heart, Lung & Blood Institute
Jeffrey Olgin, MD Eureka Research Platform: Registries NIH Natl Inst of Biomed Imaging & Bioeng
Nisha Parikh, MD FAMRI Framingham Study Internal Funding
Nisha Parikh, MD Clinical risk factors, antihypertensive use and patients with Covid-19 infection severity and progression Internal Funding
Atif Qasim, MD Disparities among Letters of Recommendation for Applicants to Cardiology Fellowship Internal Funding
Rita Redberg, MD Length of Hospital Stay and Mortality among Adults with Atrial Fibrillation Hospitalized for Bleeding During Treatment with Warfarin, Dabigatran, or Rivaroxaban Internal Funding
Rita Redberg, MD Survey of medical trainee participation in JAMA IM editorial board Internal Funding
Rita Redberg, MD Modified Delphi Panel for A Bioethical Framework to Inform Use of Novel Drugs, Devices, and Digital Health Technologies Approved with Incomplete Evidence The Greenwall Foundation
Matthew Springer, PhD Effects of chronic marijuana use on endothelial function Internal Funding
Matthew Springer, PhD  COVID-19-induced risks of thrombosis and vascular dysfunction among marijuana, cigarette and e-cigarette users Internal Funding
Geoff Tison, MD Analysis of Azumio stepcount, heart rate deidentified data - COVID Internal Funding
Zian Tseng, MD Review and Autopsy of Inpatient Code Deaths NIH MIscellaneous Other
Zian Tseng, MD  Cohort of first-degree relatives of sudden cardiac death victims (KINLIST) NIH Natl Heart, Lung & Blood Institute
Vasanth Vedantham, MD  Development of a Prospective Cardiac Sarcoidosis Registry Internal Funding
Vasanth Vedantham, MD  Outcomes in Cardiac Sarcoidosis Internal Funding
Yerem Yeghiazarians, MD Serum, DNA and Cardiac Tissue Collection Internal Funding
Yerem Yeghiazarians, MD  Assessment of Cellular Viability Internal Funding

Clinical Trials

Liviu Klein, MD Tailored Drug Titration Using Artificial Intelligence SBIR- NIH/Optima
Eveline Stock, MD Multi-center Cross-sectional Epidemiological Study to Characterize the Prevalence and Distribution of Lipoprotein(a) Levels Among Patients With Established Cardiovascular Disease Novartis
Eveline Stock, MD A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Explore the Efficacy and Safety of BIO89-100 in Subjects with Severe Hypertriglyceridemia 89Bioi, Inc.